newsfilter
← Latest News
GlobeNewswire·

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

  • BridgeBio Pharma's board compensation committee approved restricted stock unit grants for 80 new employees on November 5, 2026.
  • The aggregate equity grant consists of 147,578 shares of common stock.
  • Vesting begins with one-fourth of the shares on November 16, 2027, followed by quarterly vesting of the remaining shares in one-twelfth increments.
  • Vesting is contingent upon continued employment with BridgeBio or its subsidiaries on the respective dates.
  • The awards were granted as inducement material to new hires in compliance with Nasdaq Listing Rule 5635(c)(4) under the company's equity plan.
  • The equity plan was originally adopted in November 2019 \& amended \& restated on February 10, 2023 \& December 13, 2023.
Company
BridgeBio Pharma, Inc.
Keywords
Nasdaq:BBIO, BridgeBio Pharma, Inc.